Standard Family Office’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-700
Closed -$73K 463
2022
Q3
$73K Hold
700
0.03% 95
2022
Q2
$74K Buy
+700
New +$83K 0.73% 40
2022
Q1
Sell
-634
Closed -$78K 246
2021
Q4
$78K Buy
634
+222
+54% +$29.1K 0.69% 43
2021
Q3
$59K Sell
412
-1,321
-76% -$194K 0.02% 50
2021
Q2
$271K Buy
1,733
+412
+31% +$66.7K 0.06% 124
2021
Q1
$205K Sell
1,321
-412
-24% -$63.8K 0.05% 123
2020
Q4
$259K Buy
+1,733
New +$245K 0.06% 105

Other funds holding ZBH

Standard Family Office's ZBH Position: Q4 2022 in Review

Standard Family Office sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 700 shares — an estimated $73K sold.

Standard Family Office first reported a position in ZBH in Q4 2020 and held it in 7 quarters. The position peaked at $271K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Standard Family Office reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 700 Zimmer Biomet shares in Q4 2022, an estimated $73K.
  • Standard Family Office first reported a position in Zimmer Biomet in Q4 2020 and held it in 7 quarters.
  • Standard Family Office's Zimmer Biomet position peaked at $271K in Q2 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.